Pyrantel

This classification denotes an antihelminthic agent with the molecular formula C11H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4QIH0N49E7, chemically known as pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)-, (e)- but generally known as pyrantel, which bears US NIH Compound Identifier 708857. European Medicines Agency schedules Pyrantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10162MIG. The term PYRANTEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules pyrantel in its Anatomical Therapeutic Chemical (ATC) Classification. PYRANTEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pyrantel under HS 29349990 and SITC 51579. As of Q4 2014, PYRANTEL remains the US FDA Preferred Term for this commodity. Pyrantel bears US NLM identifiers UMLS ID C0034235 and NCI Concept Code C75231. SMILES: CN1CCCN=C1C=CC2=CC=CS2.